Impact of Dual Antiplatelet Therapy after Lower Extremity Revascularization for Chronic Limb Threatening Ischemia (CLTI)

The optimal antiplatelet regimen after lower extremity revascularization in patients with chronic limb threatening ischemia (CLTI) is unknown since current recommendations are based on extrapolation of data from trials in coronary artery disease and stroke.

Source: Journal of Vascular Surgery - May 19, 2021 Category: Surgery Authors: Bala Ramanan, Haekyung Jeon-Slaughter, Xiaofei Chen, Vikram S. Kashyap, Melissa L. Kirkwood, Carlos H. Timaran, J. Gregory Modrall, Shirling Tsai Source Type: research